New research claims that the minimally invasive MRI-guided transurethral ultrasound ablation (Tulsa) treatment effectively treats prostate cancer with minimal side effects. The Tulsa method is designed to deliver precise doses of sound waves to diseased prostate tissue while sparing the healthy nerve tissue that surrounds the prostate. The method rivals current techniques that lack sophisticated…
Glaukos (NYSE:GKOS) announced today that it entered into a collaboration and marketing agreement with Radius XR.
Aerin Medical today announced positive two-year data backing the use of its non-invasive nasal airway obstruction (NAO) treatment.
ReCor Medical today applauded updated and expanded recommendations for managing arterial hypertension overseas.
Inogen (Nasdaq: INGN) announced today that it entered into a definitive agreement to acquire Physio-Assist.
CurvaFix announced today that it closed a $39 million equity financing and named Mark Foster as its new CEO.
Boston Scientific (NYSE:BSX) announced today that the FDA approved its Vercise Neural Navigator 5 software.
Shifamed portfolio company Adona Medical today announced the introduction of its next-generation heart failure platform.
Stryker (NYSE: SYK) announced today that it launched its Q Guidance System with cranial guidance software.
Tandem Diabetes Care (Nasdaq:TNDM) announced today that the FDA cleared its Tandem Mobi automated insulin delivery (AID) system.
Philips has a new partnership with Biotronik. The deal expands the range of cardio devices available for Philips SymphonySuite customers.
